focus -WSS

focus

author：leisure time 2025-09-30 00:37:38 - browse：8623

Golden brain and DNA spiral illustration. -- biotech coverage from STAT — Adobe

The dream of being able to pluck a cell therapy off of a freezer shelf and speedily give it to cancer patients is materializing in the cancer world. Now, a new biotech hopes to do the same for patients with neurological conditions.

Kenai Therapeutics closed a $82 million Series A round Thursday co-led by Cure Ventures, The Column Group, and sovereign wealth fund Alaska Permanent Fund Corp. The San Diego-based biotech has big plans for that money — it’s already identified its lead drug candidate for people with Parkinson’s disease, and plans to move into a clinical trial within the next year.

Kenai — pronounced key-nigh — is developing therapies that use induced pluripotent stem cells, or iPSCs. These highly versatile organisms are derived from skin or blood cells and can be transformed into any type of cell. In Parkinson’s, the idea is that these cells would replace damaged neurons.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Analysis of telehealth claims data suggest service duplication

leisure time

WSS

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

FDA rejects Alnylam's heart disease treatment over insufficient data

Liquid biopsy for lung cancer is launched by Delfi

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

Doctors have an ethical obligation to be advocates

focus

focus

hotspot

Sports medicine is finally prioritizing gender equality

Transgender women dream of pregnancy via uterus transplants

Hollywood unions extend contract negotiations for actors

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

Jerome Adams on the need for new antivirals for Covid

How a key Senate committee is planning to regulate PBMs

DIEP, the 'gold standard' of breast reconstruction, is under threat

Bristol 'take

The cancer drug shortage isn’t new — and neither are the solutions

Histogen: Failed biotech offers rare public look inside

hotspot

Malaysia cuts short music fest after British band slams anti

Bristol 'take

A virus, fished out of a lake, may have saved a man’s life

Burning questions about Delta and the next phase of the Covid pandemic

Where does female orgasm come from? Scientists think they know

Where does female orgasm come from? Scientists think they know

Wikipedia

leisure time

entertainment

Wikipedia